Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

58.75
-1.8400-3.04%
Pre-market: 58.26-0.4900-0.83%04:31 EDT
Volume:3.32M
Turnover:197.27M
Market Cap:33.90B
PE:31.51
High:60.71
Open:60.45
Low:58.64
Close:60.59
52wk High:64.38
52wk Low:34.63
Shares:576.94M
Float Shares:392.53M
Volume Ratio:0.75
T/O Rate:0.85%
Dividend:0.91
Dividend Rate:1.55%
EPS(TTM):1.86
EPS(LYR):1.78
ROE:13.97%
ROA:5.09%
PB:4.96
PE(LYR):32.98

Loading ...

Royalty Pharma Maintains Quarterly Dividend at $0.235 a Share, Payable on Sept. 10 to Shareholders of Record on Aug. 14

MT Newswires Live
·
Jul 18

Press Release: Royalty Pharma Declares Third Quarter 2026 Dividend

Dow Jones
·
Jul 18

Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 16

Royalty Pharma to Report Q2 2026 Results, Host Conference Call

Reuters
·
Jul 16

Royalty Pharma to Announce Second Quarter 2026 Financial Results on August 5, 2026

THOMSON REUTERS
·
Jul 16

Royalty Pharma : TD Cowen Raises Target Price to $65 from $50

THOMSON REUTERS
·
Jul 13

Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX)

TIPRANKS
·
Jul 10

Royalty Pharma EVP Christopher Hite Sells USD 7.38 Million in Common Shares

Reuters
·
Jul 03

Royalty Pharma Forecasts Q2 Portfolio Receipts at $740 Million-$760 Million

Reuters
·
Jul 01

Royalty Pharma EVP, Chairman Partnering Christopher Hite Sells USD 8.15 Million in Common Shares

Reuters
·
Jun 26

Don't Ignore The Insider Selling In Royalty Pharma

Simply Wall St.
·
Jun 18

Royalty Pharma to join Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
Jun 05

Royalty Pharma shareholders elect nine directors at annual meeting

Reuters
·
Jun 05

Royalty Pharma CFO Terrance P. Coyne disposes of 64,399 shares worth $3.48 million

Reuters
·
May 29

BRIEF-Royalty Pharma - Enters Revolving Credit Agreement On May 22, 2026

Reuters
·
May 29

Royalty Pharma - Revolving Credit Facility to Mature on May 22, 2031 - SEC Filing

THOMSON REUTERS
·
May 29

Royalty Pharma - Credit Agreement Provides for $1.8 Bln Unsecured Revolving Credit Facility - SEC Filing

THOMSON REUTERS
·
May 29

Royalty Pharma signs USD 1.8 billion revolving credit facility, refinancing 2021 loan agreement

Reuters
·
May 29

How Investors May Respond To Royalty Pharma (RPRX) Strong Q1 Royalties And Expanding Biotech Partnerships

Simply Wall St.
·
May 28

Royalty Pharma EVP Marshall Urist sells 13,684 shares for $721,846.84

Reuters
·
May 22